EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte Studie

Comparison of Different Acellular Dermal Matrix in Breast Reconstruction: A Skin-to-Skin Study

Steven P Davison, Skylar Harbour, Eliana Fassihi

Aesthetic Surgery Journal · 2024

DOI: 10.1093/asj/sjae035 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Aesthetic Surgery Journal, 2024. Verfasst von Steven P Davison und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acellular Dermis, Seroma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: AlloDerm SELECT, DermACELL.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Since the early 2000s, acellular dermal matrix has been a popular adjunct to prepectoral breast reconstruction to enhance outcomes.

Objectives

The aim of this study was to investigate the differences in the postoperative course of 2 standard acellular dermal matrix products, AlloDerm SELECT Ready To Use and DermACELL.

Methods

A prospective, patient-blind study of patients undergoing bilateral nipple and/or skin-sparing mastectomies with either tissue expander or silicone implant insertion between 2019 and 2022 were selected for this study. The study design used patients as their own controls between 2 products randomly assigned to the left or right breast. Outcomes between the products included average time for drain removal, infection rate, seroma rate, and incorporation rates.

Results

The prospective clinical data of 55 patients (110 breasts) were recorded for 90 days. There were no significant differences between drain removal time, average drain output, or seroma aspiration amount. A higher percentage of seromas was recorded in the breasts with AlloDerm (30.91%) compared with breasts containing DermACELL (14.55%, P < .05), and a statistically significant difference between the incorporation rates of AlloDerm (93.4%) and DermACELL (99.8%, P < .05) was observed.

Conclusions

Irrespective of patient demographic disparities, both products had a 94.55% success rate for reconstruction outcomes. AlloDerm was determined to have a higher incidence of seromas as a postoperative complication and a trend to lower incorporation. Level of Evidence: 3

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acellular DermisSeromaHumansFemaleProspective StudiesMiddle AgedAdultMammaplastyBreast ImplantationBreast ImplantsTreatment OutcomeCollagenPostoperative ComplicationsTissue Expansion DevicesBreast NeoplasmsDrainageTissue ExpansionSingle-Blind Method

Substanzen

AllodermCollagen

Förderung

  • AlloDerm SELECT
  • DermACELL

Zitieren

APA

Davison, S. P., Harbour, S., & Fassihi, E. (2024). Comparison of Different Acellular Dermal Matrix in Breast Reconstruction: A Skin-to-Skin Study. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjae035

Vancouver

Davison SP, Harbour S, Fassihi E. Comparison of Different Acellular Dermal Matrix in Breast Reconstruction: A Skin-to-Skin Study. Aesthetic Surgery Journal. 2024. doi:10.1093/asj/sjae035

BibTeX
@article{Davison2024,
  author = {Davison, Steven P and Harbour, Skylar and Fassihi, Eliana},
  title = {Comparison of Different Acellular Dermal Matrix in Breast Reconstruction: A Skin-to-Skin Study},
  journal = {Aesthetic Surgery Journal},
  year = {2024},
  doi = {10.1093/asj/sjae035}
}
Kostenlos starten →